Compositions for the treatment of IRD and ARDS comprising at least one carbohydrate corticosteroid in combination with a pulmonary surfactant

摘要

Novel compositions for the treatment of IRDS and ARDS contain at least one glucocorticosteroid and a pulmonary surfactant. The duration of treatment with these compositions and the mortality associated with these syndromes can be significantly reduced with the administration of these compositions.